8-K: Current report
8-K: Current report
8-K: Current report
8-K: Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
8-K: Current report
8-K: Current report
8-K: Telesis Bio Reports First Quarter 2024 Financial Results
8-K: Current report
DEF 14A: Definitive information statements
8-K: Current report
TELESIS BIO | PRE 14A: Preliminary proxy statements relating to merger or acquisition
TELESIS BIO | 8-K: Current report
TELESIS BIO | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
TELESIS BIO | 8-K: Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
TELESIS BIO | 8-K: Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
TELESIS BIO | 8-K: Current report
TELESIS BIO | 8-K: Telesis Bio Reports Third Quarter 2023 Financial Results
TELESIS BIO | 8-K: Current report
TELESIS BIO | 8-K: Current report
TELESIS BIO | 8-K: Current report
No Data